Scientists to study how abnormal protein drives ALS
The Robert Packard Center for ALS Research at Johns Hopkins and ALS United will fund a preclinical study investigating how…
Articles by Andrea Lobo, PhD
New interactive tool provides free access to real-world ALS data
The ALS Association has launched the ALS Focus Data Dashboard, a free interactive tool that gives researchers, clinicians, and…
Insitro, Bristol Myers extend research into new drug for ALS
Bristol Myers Squibb is extending a research collaboration with the artificial intelligence company Insitro to design new medicines…
Life Time hosts nationwide fitness fundraiser for ALS research
Life Time will host a nationwide fitness event Oct. 25 to raise funds for ALS research and children’s health.
Trial in Australia, Europe will test heart drug in ALS patients
A clinical trial in Australia and Europe will test whether trimetazidine, a medication commonly used to treat heart conditions, could…
FDA clears troculeucel for expanded access program
NKGen Biotech said it’s been cleared to launch an expanded access program (EAP) that will allow patients in the U.S.
Neurizon, Elanco sign deal to advance ALS therapy NUZ-001
Neurizon Therapeutics has entered into a global licensing deal with Elanco Animal Health to advance the development of…
Usnoflast well tolerated, shows signs of efficacy in ALS patients
An experimental oral treatment from Zydus Lifesciences was well tolerated at all tested doses and showed signs of slowing…
Zydus’ usnoflast wins FDA’s fast track drug status for treating ALS
The U.S. Food and Drug Administration (FDA) has granted fast track status to usnoflast, Zydus Lifesciences’ experimental oral inhibitor,…
ALS Network collaborates on $300K drug-repurposing study
The ALS Network will support a collaborative research effort, at California’s Lawrence Livermore National Laboratory, that will use electronic…